Centronuclear Myopathy, CNM
This muscle disorder is characterized by exercise intolerance, weight loss, and muscle wasting. CNM stems from a mutation in the PTPLA gene which codes for an enzyme important for a number of cellular processes. Loss of PTPLA function is thought to cause muscle fiber damage and death, leading to replacement of the muscle mass with scar tissue.
-
Signs and symptoms
Signs include muscle weakness, wasting, and loss of muscle control leading to difficulty walking, eating and even breathing.
While abnormal tendon reflexes can be observed as early as 1 month, the symptoms of exercise intolerance and weight loss can be observed by 2 to 4 months of age. -
Diagnosis
Genetic testing, clinical signs, and muscle biopsy can be used to diagnose this disorder.
-
Treatment
There is no treatment for CNM, and most owners opt for euthanasia due to poor quality of life.
-
What to do if your dog is at risk
Actions
- Keeping your affected dog comfortable and giving them the best quality of life you can are the only actions you can take at home.
-
Genetic Information
This mutation was first described in Labrador Retrievers.
This disease is inherited in an autosomal recessive manner, meaning that affected dogs must have two copies of the mutation to show clinical signs.
Gene names:
PTPLA ‐ chr
Inheritance type:
recessive
Citations:
-
Breeds affected
This health condition affects the following breeds
Learn about your dog’s unique genetic health
Dog owners
Breed identification, health and trait insights, personalized care recommendations, and the world’s first canine relative finder—all in one leading dog DNA test.
Learn about the report for dog ownersShop the test
Breeding programs
Embark’s test for breeding programs is one comprehensive DNA test designed with your needs in mind.
Learn about the report for breedersShop the test
